Evidence map›Paper›PMID 41530264›Full record

ArticleScientific reports2026

Epidemiologic survey of ulcerative colitis and crohn's disease in Japan using claim data.

Yuka Shitara, Ayako Maeda-Minami, Hideki Ishikawa, Michihiro Mutoh, Yasunari Mano

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuka ShitaraFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1, Niijyuku, Katsushika-ku, Tokyo, 125-8585, Japan.
Ayako Maeda-MinamiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1, Niijyuku, Katsushika-ku, Tokyo, 125-8585, Japan. ayako.maeda@rs.tus.ac.jp.
Hideki IshikawaDepartment of Molecular-Targeting Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Michihiro MutohDepartment of Molecular-Targeting Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Yasunari ManoFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1, Niijyuku, Katsushika-ku, Tokyo, 125-8585, Japan.

Funding

Japan Agency for Medical Research and Development 24ck0106806h0002
6 · The paper itself

Abstract

We aimed to clarify the status of ulcerative colitis (UC) and Crohn's Disease (CD), identify the proportion of patients who visited only clinics, and obtain data to support the nationwide survey using a claims database including records of hospital and clinic visits. An epidemiological survey of hospitals and clinics was conducted using a nationwide claims database to estimate the prevalences of UC and CD in the same year as the nationwide survey. The proportion of patients who visited only clinics was calculated. Patients with UC were divided into two groups: those who visited only clinics and those who visited hospitals. UC and CD prevalence rates per 100,000 population were 227.9 and 58.2, respectively. Approximately 35% and 12% of patients with UC and CD, respectively, visited only clinics. Multivariate logistic regression analysis adjusted for patient background showed that patients who visited only clinics were older, had milder comorbidities, and incurred lower UC treatment costs than patients who visited hospitals. Epidemiological surveys using the claims database revealed that 35% of patients with UC visited only clinics. Therefore, the actual prevalence rates of patients with UC are expected to be higher than those reported in the nationwide survey, which included only hospital visits.

Indexed as

Colitis, UlcerativeCrohn DiseaseAdolescentAdultAgedDatabases, FactualFemaleHumansJapanMaleMiddle AgedPrevalenceYoung AdultClaims dataCrohn’s diseaseEpidemiologic surveyPrevalence rateUlcerative colitis

Identifiers

PMID41530264
PMCPMC12881566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.